www.fdanews.com/articles/147080-versartis-announces-publication-of-preclinical-data-for-once-monthly-human-growth-hormone-treatment-in-journal-of-pharmaceutical-sciences

Versartis Announces Publication of Preclinical Data for Once Monthly Human Growth Hormone Treatment in Journal of Pharmaceutical Sciences

June 8, 2012

Versartis announced today that its manuscript “A Novel Long-Acting Human Growth Hormone Fusion Protein (VRS-317): Enhanced In Vivo Potency and Half-Life” was published in the online edition of The Journal of Pharmaceutical Sciences.
MarketWatch